# Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia

> **NCT03108690** · PHASE4 · WITHDRAWN · sponsor: **Sara Thønnings**

## Conditions studied

- Bacteremia

## Interventions

- **DRUG:** Continuous infusion of beta-lactam antibiotics .
- **OTHER:** Therapeutic drug monitoring of beta-lactam antibiotics.

## Key facts

- **NCT ID:** NCT03108690
- **Lead sponsor:** Sara Thønnings
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-10-01
- **Primary completion:** 2023-03-09
- **Final completion:** 2023-03-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Logistics
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03108690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03108690, "Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03108690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*